Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

Press releases published on November 5, 2026

an hour ago

Monte Rosa Therapeutics Announces Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

an hour ago

Opus Genetics Completes Dosing in Cohort 2 of Phase 1/2 Clinical Trial of OPGx-BEST1 Gene Therapy for Inherited Retinal Diseases

Indeterminate GlobeNewswire

an hour ago

Entrada Therapeutics Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

an hour ago

Climb Bio Reports Third Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

an hour ago

Cartesian Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

an hour ago

Lexicon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Clinical Updates

Indeterminate GlobeNewswire

an hour ago

Zenas BioPharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

an hour ago

Vima Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial for Parkinson’s Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

Indeterminate GlobeNewswire

an hour ago

Avalo Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Updates

Indeterminate GlobeNewswire

an hour ago

C4 Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

an hour ago

Gain Therapeutics Announces Late-Breakers and Poster Presentations at Upcoming Scientific Conferences

Indeterminate GlobeNewswire

an hour ago

Pyxis Oncology Reports Third Quarter 2026 Financial Results and Highlights Progress Toward Pivotal Development of Micvotabart Pelidotin (MICVO)

Indeterminate GlobeNewswire

an hour ago

Iovance Biotherapeutics Reports Record Third Quarter 2026 Revenue of ~$122M, Business Achievements, and Corporate Updates

Indeterminate GlobeNewswire

an hour ago

Akebia Therapeutics Reports Positive Topline Data from VOCAL Trial Showing Vadadustat Dosed TIW Met Primary Endpoint of Non-Inferiority to ESA in Maintaining Hemoglobin

Indeterminate GlobeNewswire

an hour ago

Azora Therapeutics Appoints Board of Directors with Extensive Drug Development and Inflammatory Bowel Disease Expertise

Indeterminate GlobeNewswire

an hour ago

Korro Reports Third Quarter 2026 Financial Results and Provides Corporate Update 

Indeterminate GlobeNewswire

an hour ago

NetraMark's NetraAI Solution is Named Analytics Platform of the Year in the 2026 BioTech Breakthrough Awards

Indeterminate GlobeNewswire

an hour ago

Weight Watchers Announces Third Quarter 2026 Results

Indeterminate GlobeNewswire

an hour ago

Certara Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

an hour ago

Apyx Medical Corporation Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire